Terkko Navigator / Cardiology/ Feeds

Instructions for Authors

Plasma miR-126 and miR-143 as Potential Novel Biomarkers for Cerebral Atherosclerosis

Endovascular Treatment of Recurrent Chylopericardium: In vivo Demonstration of Chylopericardial Connections

Optimal positioning of the inferior vena cava cannula during cardiac surgery in children

Thyroid hormone replacement in brain-dead organ donors: should it be standard of care or is it still too soon to tell?

Defining a 'frequent admitter' phenotype among patients with repeat heart failure admissions.

Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry.

Predicting one-year mortality in heart failure using the 'Surprise Question': a prospective pilot study.

Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registry.

Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve interventions (TRAMI) registry.

March 2018 at a glance: clinical trials, co-morbidities and treatment of mitral regurgitation.

The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC.

Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study.

Left ventricular ejection fraction and heart failure: an indissoluble marriage?

Patient experience in clinical trials: results of a survey.

Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure.

Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.

Left ventricular ejection fraction in heart failure: a clinician's perspective about a dynamic and imperfect parameter, though still convenient and a cornerstone for patient classification and management.

Paroxysmal bradyarrhythmias are frequent among heart transplant recipients with unexplained syncope: a study based on implantable loop recorders.

Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF.

Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF.

Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.

Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study.

Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.

Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.

Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial.

Left ventricular geometry as a major determinant of left ventricular ejection fraction: physiological considerations and clinical implications.

Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality.

Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).

Safety and efficacy of MitraClip™ therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve interventions (TRAMI) registry.

Obesity-associated mortality risk: chronic kidney disease in focus

Reply to“racial and gender disparities among patients with Takotsubo syndrome”

Racial and gender disparities among patients with Takotsubo syndrome

‘If You Fall Down, You Have to Climb up Again’

Is Bigger Actually Better? The Strengths and Limitations of Large Registry Data

Progressive Guidance on the Modern Management of Abdominal Aorto-iliac Artery Aneurysms

Micro-mesh technology in routine CAS: the final piece of the puzzle?

The importance of large animal atherosclerosis models in studying the response to polymers and drug-eluting stents.

Concomitant mitral regurgitation: an insidious cause of lowflow, low-gradient severe aortic stenosis.

Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.

MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.

Cyclic peptide RD808 reduces myocardial injury induced byβ 1 -adrenoreceptor autoantibodies

CardioMEMS in a Busy Cardiology Practice: Less than Optimal Implementation of a Valuable Tool to Reduce Heart Failure Readmissions.

Assessing response to cardiac resynchronization therapy: Time to settle on some definitive criteria.

Cardiac papillary fibroelastoma: So small and yet so dangerous.

Enhanced pacing modalities in bradycardia patients: Can technology reduce costs?

Impact on long-term cardiovascular outcomes of different cardiac resynchronization therapy response criteria.

Who is too fat?

Letter in response to "the role of succinate and ROS in reperfusion injury - A critical appraisal" by Andrienko et al.

Accelerated coronary atherosclerosis not explained by traditional risk factors in 13% of young individuals.